| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41575-019-0168-0 |
| P698 | PubMed publication ID | 31197261 |
| P50 | author | Ian A Rowe | Q42293609 |
| Richard Parker | Q56850138 | ||
| P2860 | cites work | Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis | Q30238749 |
| Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States | Q36756206 | ||
| Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease | Q38627907 | ||
| The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe | Q39471203 | ||
| Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. | Q40084558 | ||
| Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease | Q49647333 | ||
| High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound | Q73966309 | ||
| P433 | issue | 8 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| P304 | page(s) | 449-450 | |
| P577 | publication date | 2019-08-01 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | The diagnosis of nonalcoholic fatty liver disease should carry important prognostic information | |
| P478 | volume | 16 |
| Q90055630 | On the path to detecting significant liver disease | cites work | P2860 |
Search more.